GLP-1 receptor agonists are intended for adults with obesity (BMI 30) or those who are overweight (BMI 27) with associated metabolic conditions such as hypertension, dyslipidaemia, or type 2 diabetes
The concept is not unique to tirzepatide
The reduced precision at this syringe size is partially offset by the larger dose, where a 2-unit variation represents a smaller percentage error
Revised: 12/2025 Full Prescribing Information WARNING: SERIOUS INFECTIONS AND MALIGNANCY SERIOUS INFECTIONS Patients treated with HUMIRA are at increased risk for developing serious infections that may lead to hospitalization or death [see Warnings and Precautions (5.1)]
Timing your injections strategically The day of the week you inject matters more than most people realize when BUDs are tight
Colloquially, BPC-157 is referred to as the "wolverine peptide," and it's often "stacked" with another peptide, TB-500